Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability

by S. Karkampouna, F. La Manna, M.R. De Filippo, M. De Menna, E. Zoni, J. Grosjean, I. Klima, A. Garofoli, V. Genitsch, D. Keller, T.H. Booij, C.U. Stirnimann, A. Sboner, C.K.Y. Ng, S. Piscuoglio, M. Spahn, A.R. Mark, G.N. Thalmann, M. Kruithof-De Julio
Published 2020-07-01